Assessing the Safety and Efficacy of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) in the Treatment of Rett Syndrome (RTT)
Latest Information Update: 10 Oct 2024
At a glance
- Drugs NTI 164 (Primary)
- Indications Rett syndrome
- Focus Therapeutic Use
- 10 Oct 2024 New trial record